The 47th Annual Meeting of the Molecular Biology Society of Japan
Nov 26 - Nov 29, 2024Fukuoka International Congress Center・Marin Messe Fukuoka Hall A, B（11/27～11/29）/ Online（11/26）
The 47th Annual Meeting of the Molecular Biology Society of Japan
Nov 26 - Nov 29, 2024Fukuoka International Congress Center・Marin Messe Fukuoka Hall A, B（11/27～11/29）/ Online（11/26）
[3P-330]Candidate therapeutic compounds selection rule for the xeroderma pigmentosum complementation group D mutant (R683W) as determined by in silico drug repurposing screening
○Aki Sugano1,2,4, Mika Ohta2,3, Satoshi Tateishi5, Yoshimasa Maniwa2, Yutaka Takaoka2,3,4(1. CCTR, Toyama Univ. Hosp., 2. Dept. of Med. Syst., Kobe Univ. Grad. Sch. of Med., 3. Dept. of Comput. Drug Design and Math. Med., Grad. Sch. of Med. and Pharma. Sci., Toyama Univ., 4. Center for DS and AI Res. Promot., Toyama Univ. Hosp., 5. Dept. of Cell Maintenance, IMEG Kumamoto Univ.)
Password required to view
This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.